Top Stories

Montagu Private Equity, Lee Equity Partners and Webster Equity Partners are among the PE firms investing in the cardiology market.

The private equity firm is in the early stages of launching several sale processes.

2025 is likely to be a transitional year for the shift to renewable energy, though strategic M&A processes may well see pause until clarity is known about the Investment Tax Credit and Production Tax Credit.

'We’ve seen several high-profile transactions in life sciences, resulting in big exits for investors in the private and public markets,' said Toby Sykes, managing director of Intermediate Capital Group.

The firm's deals in 2024 include AuditBoard, CTAIMA, Cube, Empyrean, Focus Group, Induver, Ivalua and Ncontracts.

Consultancy companies covering management, climate and sustainability, and IT were among the deals.

GPs are finding attractive price-to-earnings ratios in the UK – as well as willing sellers.

The iconic brand’s recognition value, coupled with dance’s health benefits, were among the target company’s attractions for the PE firm.

Family office Vonrosen is entirely focused on direct investments – usually with majority control – but is sector-agnostic, its founder tells PE Hub.

Private equity has put its faith in the travel industry and shaken off anti-tourism concerns.